학술논문
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies
Document Type
Article
Author
Source
In: Expert Opinion on Drug Discovery . (Expert Opinion on Drug Discovery, 2023, 18(10):1065-1076)
Subject
Language
English
ISSN
1746045X
17460441
17460441